Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products

Bone Marrow Transplantation

Volumn 23, Issue 1, 1999, Pages 63-69

  Ageitos, A G ^a   Varney, M L ^a   Bierman, P J ^a   Vose, J M ^a   Warkentin, P I ^a   Talmadge, J E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

G CSF; GM CSF; Monocytes; Stem cell mobilization; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; PHYTOHEMAGGLUTININ;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MITOGENESIS; MOBILIZATION; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033008330     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701524     Document Type: Article

References (61)

1. Brugger W, Bross K, Frisch J et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 1992; 79: 1193-1200.
2. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New Engl J Med 1992; 327: 99-106.
3. Sharp JG. Micrometastases and transplantation. J Hematother 1996; 5: 519-524.
4. To LB, Roberts M, Haylock D. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
5. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
6. Talmadge JE, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161-172.
7. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
8. Ashihara E, Shimazaki C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two color cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
9. Talmadge JE, Reed EC, Kessinger A et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
10. Atkinson K. Reconstitution of the hematopoietic and immune recovery systems after human marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
11. Foot ABM, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7-13.
12. To LB, Shepperd KM, Haylock DN et al. Single high-doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990; 18: 442-447.
13. Copelan EA, Ceselski SK, Ezzone SA et al. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma and Hodgkin's disease. J Clin Oncol 1997; 15: 759-765.
14. To LB, Haylock DN, Dowse T et al. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 1994; 84: 2930-2939.
15. Siena S, Bregni M, Brando B et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
16. Pettengell R, Demuynck H, Testa NG, Dexter TM. The engraftment capacity of peripheral blood progenitor cells (PBPC) mobilized with chemotherapy+G-CSF. Int J Cell Cloning 1992; 10: 59.
17. Tarella C, Ferrero D, Bregni M et al. Peripheral blood expansion of early progenitor cells after high dose cyclophosphamide and rH GM-CSF. Eur J Cancer 1991; 27: 22-27.
18. Nemunaitis J. Cytokine-mobilized peripheral blood progenitor cells. Semin Oncol 1996; 23: 9-14.
19. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
20. Vose JM, Bierman PJ, Kessinger A et al. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Bone Marrow Transplant 1991; 7: 139-143.
21. Kessinger A. Circulating stem cells: waxing hematopoietic. New Engl J Med 1995; 333: 315-316.
22. Haas R, Ho D, Bredthauer U et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990; 18: 94-98.
23. Pettengell R, Testa NG, Swindell R et al. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993; 82: 2239-2248.
24. Hansson M, Svensson A, Engervall P et al. Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration. Eur J Haematol 1995; 54: 321-328.
25. Lobo F, Kessinger A, Landmark JD et al. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy. Bone Marrow Transplant 1991; 8: 389-392.
26. Weisbart RH, Golde DW, Clark SC. Human granulocyte-macrophage colony-stimulating factor is neutrophil activator. Nature 1985; 314: 361-363.
27. Schwarzmeier JD. The role of cytokines in haematopoiesis. Eur J Haematol 1996; 57: 69-74.
28. Richard C, Baro J, Bello-Fernandez C et al. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. Bone Marrow Transplant 1995; 15: 721-726.
29. Dreger P, Suttorp M. Influence of G-CSF on NK cell recovery after autologous BMT. Bone Marrow Transplant 1996; 13: 667-668.
30. Fabian I, Kletter Y, Bleiberg I et al. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation. Exp Hematol 1991; 19: 868-873.
31. Bennett CL, Smith TJ, Weeks JC et al. Use of hematopoietic colony-stimulating factors: The American Society of Clinical Oncology Survey. J Clin Oncol 1996; 14: 2511-2520.
32. Schimitz N, Dreger P, Zander AR et al. Results of a randomized, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Bone Marrow Transplant 1995; 15: 261-266.
33. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996; 88: 761-777.
34. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991; 77: 1131-1145.
35. DeLuca E, Sheridan WP, Watson D et al. Prior chemotherapy does not prevent effective mobilization by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992; 66: 893-899.
36. Socinski MA, Elias A, Schnipper L et al. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 1: 1194-1198.
37. Dreger P, Marquardt P, Haferlach T et al. Effective mobilization of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. Br J Cancer 1993; 68: 950-957.
38. Mills KC, Gross TG, Varney ML et al. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Bone Marrow Transplant 1996; 18: 53-61.
39. Santoli D, Clark SC, Kreider BL et al. Amplification of IL-2 driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony stimulating factor. J Immunol 1988; 141: 519-526.
40. Ho AD, Haas R, Wulf G et al. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood 1990; 75: 203-212.
41. Al-Aoukaty A, Giaid A, Sinoff C et al. Priming effects of GM-CSF are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes. Blood 1994; 83: 1299-1309.
42. Badger AM, King AG, Talmadge JE et al. Induction of nonspecific suppressor cells by a novel azaspirane, SK&F 105685, an immunomodulatory compound with therapeutic activity in animal models of autoimmune disease. J Autoimmun 1990; 3: 485-500.
43. Ino K, Singh RK, Talmadge JE. Monocytes from mobilized stem cells inhibit T cell function. J Leuk Biol 1997; 61: 583-591.
44. Ageitos AG, Ino K, Orerol I et al. Restoration of immune function in mobilized stem cell product by suppressor cell removal. Bone Marrow Transplant 1997; 20: 117-123.
45. Ageitos AG, Singh RK, Ino K et al. IL-2 Expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: monocyte inhibition. J Immunother 1999 (in press).
46. + cells in granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 1996; 87: 574-580.
47. Bolwell BJ, Goormastic M, Yanssens T et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913-918.
48. Schneider JG, Crown JP, Wasserheite CJ et al. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Bone Marrow Transplant 1994; 14: 877-884.
49. Ho AD, Young D, Maruyama M et al. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs a combination of both. Exp Hematol 1996; 24: 1460-1468.
50. San Miguel JF, Hernandez MD, Gonzalez M et al. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haematol 1996; 94: 140-147.
51. Triozzi PL, Tucker F, Benzies T, Balcerzak SP. Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant 1996; 18: 47-52.
52. Tanaka J, Mielcarek M, Torok SB. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998; 91: 347-352.
53. Singh RK, Varney ML, Ageitos AG et al. Differential cytokine expression in growth factor mobilized peripheral stem cell and bone marrow products and their immunoregulatory significance. Proc Amer Assoc Cancer Res 1997; 58: 33.
54. de Wall MR, Haanen J, Spits H et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
55. Willems F, Marchant A, Delville JP et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24: 1007-1009.
56. Bromberg JS. IL-10 immunosuppression in transplantation. Curr Opin Immunol 1995; 7: 639-643.
57. Mielcarek M, Martin PJ, Torok-Storb B. Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629-1634.
58. San-Miguel MJ, Hernandez MD, Gonzalez M et al. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haematol 1996; 94: 140-147.
59. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1996; 86: 4422-4429.
60. Nakamura Y, Noma M, Kidokoro M et al. Isolation of human CD34+ peripheral blood stem cells using an immunomagnetic nylon-wool column. J Hematother 1994; 3: 128-133.
61. Yamaguchi M, Sawada K, Sato N et al. A rapid nylon-fiber syringe system to deplete CD14+ cells for positive selection of human blood CD34+ cells. Use of immunomagnetic microspheres. Bone Marrow Transplant 1997; 19: 373-379.